(Q47311740)

13 January 2018

title

Latently infected cell activation: a way to reduce the size of the HIV reservoir? (English)

1 reference

13 January 2018

author name string

Jonathan Forde

series ordinal

1

1 reference

13 January 2018

Joseph M Volpe

series ordinal

2

1 reference

13 January 2018

Stanca M Ciupe

series ordinal

3

1 reference

13 January 2018

publication date

5 May 2012

1 reference

13 January 2018

Bulletin of Mathematical Biology

number of pages

22

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

13 January 2018

volume

74

1 reference

13 January 2018

issue

7

1 reference

13 January 2018

page(s)

1651-1672

1 reference

13 January 2018

maintained by WikiProject

WikiProject Mathematics

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s11538-012-9729-x

0 references

cites work

Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

The challenge of viral reservoirs in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Twenty years of HIV-1 non-nucleoside reverse transcriptase inhibitors: time to reevaluate their toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Combinatorial latency reactivation for HIV-1 subtypes and variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

HIV-1 infection and low steady state viral loads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Maintenance of CD4+ T-cell memory and HIV persistence: keeping memory, keeping HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Duration of an intermittent episode of viremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Hide-and-seek: the challenge of viral persistence in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Transient viremia, plasma viral load, and reservoir replenishment in HIV-infected patients on antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Activation of latent HIV using drug-loaded nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Mechanisms of HIV latency: an emerging picture of complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Decay characteristics of HIV-1-infected compartments during combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Modeling HIV persistence, the latent reservoir, and viral blips

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Central memory and effector memory T cell subsets: function, generation, and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Stability of the latent reservoir for HIV-1 in patients receiving valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

HIV-1 dynamics in vivo: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Can the viral reservoir of latently infected CD4(+) T cells be eradicated with antiretroviral HIV drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Modeling plasma virus concentration during primary HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Viral dynamics in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Hit-and-run stimulation: a novel concept to reactivate latent HIV-1 infection without cytokine gene induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Understanding the slow depletion of memory CD4+ T cells in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-012-9729-X

10.1007/S11538-012-9729-X

21 January 2018

Identifiers

DOI

1 reference

13 January 2018

1 reference

13 January 2018